# Protagonist Therapeutics, Inc: Form 8-K, filed Jun 26, 2024

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2024-06-26
- Accepted by EDGAR: Jun 26, 2024, 16:12 ET
- Period: 2024-06-20
- Accession: 0001104659-24-075162
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465924075162/tm2418234d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465924075162/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465924075162/tm2418234d1_8k.htm

Filed Jun 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-075162. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.